Bill Rote
Fortune : 7 M $ au 31/08/2026
Fortune : 7 M $ au 31/08/2026
William E.
Rote is Chief Research Officer at Travere Therapeutics, Inc. since 2017.
Former positions include Executive Director-Biologics Development at Corvas International, Inc. from 1993 to 2003, Non Executive Director at Xenome Ltd. in 2009, Vice President, Head-Research & Development at Amylin Pharmaceuticals, Inc. from 2012 to 2014, Principal at Eli Lilly & Co., Chief Operating Officer at Psylin Neurosciences, Inc., and Vice President-Clinical Development at Ardea Biosciences, Inc. from 2014 to 2016.
Education includes undergraduate and doctorate degrees from The Pennsylvania State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/09/2026 | 98 197 ( 0,11% ) | 7 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Corporate Officer/Principal | 01/07/2016 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Directeur Technique/Scientifique/R&D | 01/07/2014 |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Corporate Officer/Principal | 01/01/2003 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide hormones for the treatment of psychiatric disorders | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide hormones for the treatment of psychiatric disorders | Health Technology |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national